UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dexamethasone in hyperleukocytic acute myeloid leukemia

Haematologica (Roma), 2018-06, Vol.103 (6), p.988-998

2018

Volltextzugriff (PDF)

Somatic genetic alterations predict hematological progression in GATA2 deficiency

Haematologica (Roma), 2023-06, Vol.108 (6), p.1515-1529

2023

Volltextzugriff (PDF)

Impact of TP53 mutations in acute myeloid leukemia patients treated with azacitidine

PloS one, 2020-10, Vol.15 (10), p.e0238795-e0238795

2020

Volltextzugriff (PDF)

Genomic landscape of hyperleukocytic acute myeloid leukemia

Blood cancer journal (New York), 2022-01, Vol.12 (1), p.4-4, Article 4

2022

Volltextzugriff (PDF)

Phenotypically-defined stages of leukemia arrest predict main driver mutations subgroups, and outcome in acute myeloid leukemia

Blood cancer journal (New York), 2022-08, Vol.12 (8), p.117-117, Article 117

2022

Volltextzugriff (PDF)

Dismal outcome of refractory or relapsing patients with myelodysplasia‐related acute myeloid leukemia partially alleviated by intensive chemotherapy

Cancer medicine (Malden, MA), 2024-02, Vol.13 (3), p.e7003-n/a

2024

Volltextzugriff (PDF)

Place de la cytogénétique dans le diagnostic des leucémies aiguës myéloïdes

Revue francophone des laboratoires, 2015-04, Vol.2015 (471), p.43-49

Luquet, Isabelle

2015

Volltextzugriff (PDF)

Tyrosine Kinase Inhibitors with Intensive Chemotherapy in AML with t(9;22)(q34.1;q11.2)/ BCR::ABL1 : Time to Reconsider Prognostic Risk? a Study from the Dataml Registry

Blood, 2023-11, Vol.142 (Supplement 1), p.1473-1473

2023

Volltextzugriff (PDF)

Cytogenetics in the management of acute myeloid leukemia and histiocytic/dendritic cell neoplasms: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)

Current research in translational medicine, 2023-10, Vol.71 (4)

2023

Volltextzugriff (PDF)

Cytogenetics in the management of acute myeloid leukemia and histiocytic/dendritic cell neoplasms: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)

Current research in translational medicine, 2023-10, Vol.71 (4), p.103421-103421, Article 103421

2023

Volltextzugriff (PDF)

Cytogenetics in the management of B-cell acute lymphoblastic leukemia: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)

Current research in translational medicine, 2023-10, Vol.71 (4), p.103434-103434, Article 103434

2023

Volltextzugriff (PDF)

Cytogenetics in the management of T-cell acute lymphoblastic leukemia (T-ALL): Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)

Current research in translational medicine, 2023-10, Vol.71 (4), p.103431-103431, Article 103431

2023

Volltextzugriff (PDF)

Prognostic Impact of Unsupervised Early Assessment of Bulk and Leukemic Stem Cell Measurable Residual Disease in Acute Myeloid Leukemia

Clinical cancer research, 2023-01, Vol.29 (1), p.134-142

2023

Volltextzugriff (PDF)

The presence of a chromosomal abnormality in cytopenia without dysplasia identifies a category of high‐risk clonal cytopenia of unknown significance

Genes chromosomes & cancer, 2023-03, Vol.62 (3), p.139-151

2023

Volltextzugriff (PDF)

7q22 deletion in myeloid malignancies: be attentive to the design of the FISH probe

Annales de biologie clinique (Paris), 2019-04, Vol.77 (2), p.229-230

2019

Volltextzugriff (PDF)

Optimizing the Supportive Care of Intensive Chemotherapy in AML : Impact of Vitamin C and D Supplementation in Patients with NPM1 Mutation. a Dataml Registry Study

Blood, 2022-11, Vol.140 (Supplement 1), p.3239-3241

2022

Volltextzugriff (PDF)

Artificial Intelligence-Based Predictive Models for Acute Myeloid Leukemia

Blood, 2021-11, Vol.138 (Supplement 1), p.3389-3389

2021

Volltextzugriff (PDF)

Genomics of Hyperleukocytic Acute Myeloid Leukemia

Blood, 2021-11, Vol.138 (Supplement 1), p.1294-1294

2021

Volltextzugriff (PDF)

Stem cell-like reprogramming is required for leukemia-initiating activity in B-ALL

The Journal of experimental medicine, 2024-01, Vol.221 (1)

2024

Volltextzugriff (PDF)

Current Results of Intensive Therapy in Younger Adults with Acute Myeloid Leukemia (AML): The Large Randomized French Backbone Intergroup (BIG)-1 Study on Behalf of the Filo, ALFA, and SFGM-TC Study Groups

Blood, 2023-11, Vol.142 (Supplement 1), p.967-967

2023

Volltextzugriff (PDF)

Clinical and biological features of B‐cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities

British journal of haematology, 2021-04, Vol.193 (1), p.72-82

2021

Volltextzugriff (PDF)

Improved outcome for AML patients over the years 2000–2014

Blood cancer journal (New York), 2017-11, Vol.7 (12), p.635-9, Article 635

2017

Volltextzugriff (PDF)

Characteristic vacuolization of myeloid precursors and UBA1 mutation in a woman with monosomy X

International journal of laboratory hematology, 2022-02, Vol.44 (1), p.29-30

2022

Volltextzugriff (PDF)

Haploinsufficiency for NR3C1, the gene encoding the glucocorticoid receptor, in blastic plasmacytoid dendritic cell neoplasms

Blood, 2016-06, Vol.127 (24), p.3040-3053

2016

Volltextzugriff (PDF)

1 – 25 von 103

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(91)
Mit Volltextzugriff
(89)

Publikationsform

Sprache

Englisch
(97)
Französisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(40)
Life Sciences & Biomedicine
(38)
Humans
(24)
Life Sciences
(24)
Hematology
(23)
Oncology
(14)
Mutation
(12)
Acute Myeloid Leukemia
(10)
Leukemia, Myeloid, Acute - Genetics
(10)
Medicine, Research & Experimental
(8)
Research & Experimental Medicine
(8)
Animals
(7)
Leukemia
(7)
Prognosis
(7)
Remission
(6)
Stem Cells
(6)
Biochemistry & Molecular Biology
(5)
Bone Marrow
(5)
Cancer
(5)
Cancer Research
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Dexamethasone in hyperleukocytic acute myeloid leukemia

Somatic genetic alterations predict hematological progression in GATA2 deficiency

Impact of TP53 mutations in acute myeloid leukemia patients treated with azacitidine

Genomic landscape of hyperleukocytic acute myeloid leukemia

Phenotypically-defined stages of leukemia arrest predict main driver mutations subgroups, and outcome in acute myeloid leukemia

Dismal outcome of refractory or relapsing patients with myelodysplasia‐related acute myeloid leukemia partially alleviated by intensive chemotherapy

Place de la cytogénétique dans le diagnostic des leucémies aiguës myéloïdes

Tyrosine Kinase Inhibitors with Intensive Chemotherapy in AML with t(9;22)(q34.1;q11.2)/ BCR::ABL1 : Time to Reconsider Prognostic Risk? a Study from the Dataml Registry

Cytogenetics in the management of acute myeloid leukemia and histiocytic/dendritic cell neoplasms: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)

Cytogenetics in the management of acute myeloid leukemia and histiocytic/dendritic cell neoplasms: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)

Cytogenetics in the management of B-cell acute lymphoblastic leukemia: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)

Cytogenetics in the management of T-cell acute lymphoblastic leukemia (T-ALL): Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH)

Prognostic Impact of Unsupervised Early Assessment of Bulk and Leukemic Stem Cell Measurable Residual Disease in Acute Myeloid Leukemia

The presence of a chromosomal abnormality in cytopenia without dysplasia identifies a category of high‐risk clonal cytopenia of unknown significance

7q22 deletion in myeloid malignancies: be attentive to the design of the FISH probe

Optimizing the Supportive Care of Intensive Chemotherapy in AML : Impact of Vitamin C and D Supplementation in Patients with NPM1 Mutation. a Dataml Registry Study

Artificial Intelligence-Based Predictive Models for Acute Myeloid Leukemia

Genomics of Hyperleukocytic Acute Myeloid Leukemia

Stem cell-like reprogramming is required for leukemia-initiating activity in B-ALL

Current Results of Intensive Therapy in Younger Adults with Acute Myeloid Leukemia (AML): The Large Randomized French Backbone Intergroup (BIG)-1 Study on Behalf of the Filo, ALFA, and SFGM-TC Study Groups

Dexaml-02 : A Phase II Study of Dexamethasone Added to Induction and Postremission Therapy in Older Patients with Newly Diagnosed AML. a French Innovative Leukemia Organization (FILO) Study

Clinical and biological features of B‐cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities

Improved outcome for AML patients over the years 2000–2014

Characteristic vacuolization of myeloid precursors and UBA1 mutation in a woman with monosomy X

Haploinsufficiency for NR3C1, the gene encoding the glucocorticoid receptor, in blastic plasmacytoid dendritic cell neoplasms

Aktive Filter

Suchergebnisse filtern